| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |